Session 1
Chair: Dr Tony Rawlings |
The biology, physiology and mechanisms of skin ageing |
| Paper 1 |
Multiple mechanisms that contribute to skin ageing and impact of technologies - Dr Helen Meldrum, Unilever, USA |
| Paper 2 |
Age-related NADH oxidase (arNOX) - Dr Dale Kern, NuSkin Enterprises, USA |
| Paper 3 |
A potential role for dermal papillary fibroblasts in skin ageing - Dr Daniel Asselineau, L'Oréal, France |
| Paper 4 |
Extracellular matrix and skin photoageing - Dr Anja Knott, Beiersdorf AG, Germany |
Session 2
Chair: Dr Paul Matts |
Proving performance – 1: The measurement of the effects of cosmetics and cosmetic ingredients |
| Paper 5 |
Dynamics of genomic response, a new vision of skin ageing - Dr Bruno Bernard, L'Oréal Recherche, France |
| Paper 6 |
Antioxidant efficacy: an ‘invisible’ anti-ageing concept investigated by in vivo Chemiluminescence (ICL-S) - Dr Mathias Rohr, Institute Dr. Schrader, Germany |
| Paper 7 |
Cyclic RGD-peptide activates anti-ageing pathways in skin - Dr Rüdiger Graf, Merck KGaA, Germany |
| Paper 8 |
Elastin-enhancing agents for reversing dermal ageing - Dr Miri Seiberg, The Johnson and Johnson Skin Research Center, USA |
| Paper 9 |
Personalised anti-ageing skin care: molecular basis - Prof. Toomas Neuman, Tallin Technical University, Estonia |
| Paper 10 |
I see the light! - non-invasive measurement of molecular concentration profiles in human skin by Confocal Raman Spectroscopy - Dr Paul Matts, Procter & Gamble, UK |
Session 3
Chair: Dr Jack Ferguson |
The cosmeceutical - The physiological cosmetic |
| Keynote address |
Physiological effects of cosmetic moisturisers - Dr Tony Rawlings, AVR Consulting Ltd, UK |
| Paper 12 |
Cosmeceuticals: a dermatologist's viewpoint on the challenges faced by the consumer - Dr Steven Wang, Memorial Sloan-Kettering Cancer Center, USA |
| Paper 13 |
Cosmetics, medicines and the borderline - Simon Parker, Medicines Classifier, MHRA UK |
| Paper 14 |
International regulatory considerations - Debra Redbourn, dR Cosmetic Regulations, UK |
Session 4
Chair: Dr Chris Gummer |
Proving performance – 2: Advertising and regulatory controls on anti-ageing cosmetics |
| Paper 15 |
Statistics doesn’t have to be hard – honest! - Dr Phil Bowtell, Procter & Gamble, UK |
| Paper 16 |
US Advertising self-regulation and cosmetics claims - Annie M. Ugurlayan,
National Advertising Division, USA |
| Closing keynote |
Regulations in advertising in Europe and the future - Kristoffer Hammer, Head of Policy & Customer Operations, Clearcast, UK |
